Chairman and Executive Director Cai Dongchen increased his stake in CSPC PHARMA (01093) by 3 million shares at a price of HK$8.81 per share.
On October 17th, Chairman and Executive Director Cai Dongchen increased his holdings in Chiho Pharmaceutical Group (01093) by 3 million shares, each priced at 8.81 Hong Kong dollars, for a total amount of 26.43 million Hong Kong dollars.
The latest information from the Hong Kong Stock Exchange shows that on October 17th, Chairman and Executive Director Dong Chen Tsai increased his holdings of CSPC PHARMA (01093) by 3 million shares, with a price of 8.81 Hong Kong dollars per share, for a total amount of 26.43 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 2.842 billion shares, with the latest shareholding ratio of 24.67%.
Related Articles
Tianfeng: "Artificial intelligence +" action accelerates the landing of "AI+ applications". It is recommended to pay attention to XD INC (02400)."
Guojin Hwen Ask Non-ferrous Metals: Supply Contraction and AI Demand Resonance, Non-ferrous Sector "CommodityStock" Value Transmission in Progress.
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
Tianfeng: "Artificial intelligence +" action accelerates the landing of "AI+ applications". It is recommended to pay attention to XD INC (02400)."
Guojin Hwen Ask Non-ferrous Metals: Supply Contraction and AI Demand Resonance, Non-ferrous Sector "CommodityStock" Value Transmission in Progress.
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
RECOMMEND
